Skip to main content

FDA Authorizes Updated Novavax COVID-19 Vaccine

Medically reviewed by Drugs.com.

By Cara Murez HealthDay Reporter

WEDNESDAY, Oct. 4, 2023 -- Federal regulators on Tuesday gave the go-ahead to an updated Novavax COVID vaccine, giving Americans a more traditional alternative to two recently revamped mRNA vaccines.

Adolescents and adults who have previously received a COVID vaccine, but who haven’t gotten the newly updated Pfizer or Moderna shots, now have this non-mRNA choice.

"The COVID-19 vaccines have saved countless lives and have prevented serious outcomes of COVID-19 caused by the SARS-CoV-2 virus," Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, said in an agency news release.

"Today's authorization provides an additional COVID-19 vaccine option that meets the FDA's standards for safety, effectiveness and manufacturing quality needed to support emergency use authorization,” Marks added. “As we head into the fall season and transition into 2024, we strongly encourage those who are eligible to consider receiving an updated COVID-19 vaccine to provide better protection against currently circulating variants."

This updated shot is expected to better target variants that are circulating now and help prevent hospitalization and death from the virus. It includes the spike protein from the Omicron variant XBB.1.5.

"COVID-19 is once again on the rise with infections and hospitalizations increasing, so it's important that individuals get vaccinated to protect themselves and their loved ones," Novavax President and CEO John Jacobs said in a company news release. "Novavax's authorization today means people will now have the choice of a protein-based, non-mRNA option to help protect themselves against COVID-19, which is now the fourth leading cause of death in the U.S."

The FDA evaluated immune response and manufacturing data from the company before approving the updated shot. It also relied on clinical trial data for safety on the original Novavax vaccine and post-marketing data. This latest vaccine makes Novavax's original shot obsolete.

Novavax said it plans to ship doses of the updated vaccine soon and make them available at “thousands of locations."

Sources

  • U.S. Food and Drug Administration, news release, Oct. 3, 2023, Novavax, news release, Oct. 3, 2023

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted October 2023

Further Support and Information on COVID-19

Read this next

Vaccines Will Be Best Defense Against Bird Flu, Experts Say

WEDNESDAY, May 29, 2024 -- Humanity’s best protection against bird flu will be the development of effective vaccines, a new study says. The H5N1 avian flu has been raging...

Nations Fail to Agree on Treaty on Preventing Next Pandemic

TUESDAY, May 24, 2024 -- Following two years of tough negotiations, efforts to craft a global treaty to help countries fight future pandemics have failed, the World Health...

Scientists Developing mRNA-Based Vaccine Against H5N1 Bird Flu

TUESDAY, May 28, 2024 -- An experimental mRNA vaccine against the H5N1 avian flu is highly effective in preventing severe illness and death in lab animals, researchers...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.